David Gass to Speak on IP Rights and the Human Microbiome at 2017 BIO International Convention
Partner David A. Gass will moderate a panel addressing IP rights and the human microbiome at the 2017 Biotechnology Innovation Organization (BIO) International Convention.
2017 BIO International Convention
Monday, June 19 – Thursday, June 22, 2017
San Diego Convention Center
“Innovation and the Human Microbiome: Patent Eligibility and IP Protection”
Tuesday, June 20, 2017 from 1:45 – 2:45pm PT in Room 1B
David A. Gass, Partner, Marshall Gerstein
Amanda Barry, Associate General Counsel, Global Home Care & NA Fabric Care, The Proctor & Gamble Company
Michelle Booden, Senior Director, Technology Development; Director of Licensing and Intellectual Property, Salk Institute for Biological Studies
Simon O’Brien, Partner, Patent Attorney, D Young & Co
This panel will discuss the intellectual property challenges that exist with microbiome research, diagnosis, therapy, and product development as well as how to protect intellectual property rights. Scientists estimate that 50 – 90% of the cells in a human body are not human at all, but microbial, yet the study of the human microbiome is still in its infancy. Research is uncovering roles for microbes from prenatal and perinatal health through neurodegenerative diseases that plague us in old age; and in numerous systems of the human body unrelated to digestion and nutrition. While new directions of research are continually uncovered, traditional areas, such as antibiotic research, still pose new challenges. Attendees will hear how careful, thoughtful and creative patent drafting, trademark rights and contractual provisions can be used to protect innovations in this area.
BIO International Convention
The BIO International Convention attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
For further information on the 2017 BIO International Convention, please click here.